Effects of chronic antidepressants in an operant conflict procedure of anxiety in the rat

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 4, 1999, Pages 591-599

  Beaufour, Caroline C ^a   Ballon, Nicolas ^a   Le Bihan, Claudine ^a   Hamon, Michel ^a   Thiébot, Marie Hélène ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Anxiety; Chronic treatment; Conditioned behavioral suppression; Desipramine; Fluoxetine; Imipramine; Maprotiline; Phenelzine; Rat

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; MAPROTILINE; PHENELZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ANXIETY NEUROSIS; ARTICLE; CONDITIONING; CONFLICT; CONTROLLED STUDY; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; CONDITIONING, OPERANT; CONFLICT (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; MALE; PUNISHMENT; RATS; RATS, WISTAR; TIME FACTORS; WEIGHT GAIN;

ANIMALIA;

EID: 0032985232     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00180-4     Document Type: Article

References (48)

1. Akunne H.C., Soliman K.F.A. Serotonin modulation of pain responsiveness in the aged rats. Pharmacol. Biochem. Behav. 48:1994;411-416.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, (4th ed.). Washington, DC: American Psychiatry Press; 1994.
3. 3H]nisoxetine autoradiography. Brain Res. 582:1992;208-214.
4. Beardslee S., Papadakis E., Fontana D., Commissaris R. Antipanic drug treatments. Failure to exhibit anxiolytic-like effects on defensive burying behavior Pharmacol. Biochem. Behav. 35:1990;451-455.
5. Blanchard R.J., Shepherd J.K., Rodgers R.J., Magee L., Blanchard D.C. Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine. Psychopharmacology (Berlin). 110:1993;245-253.
6. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends. Pharmacol. Sci. 15:1994;220-226.
7. Bodnoff S., Suranyi-Cadotte B., Aitken D., Quirion R., Meaney M. The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology (Berlin). 95:1988;298-302.
8. Bodnoff S., Suranyi-Cadotte B., Quirion R., Meaney M. A comparison of the effects of diazepam versus several typical and atypical antidepressant drugs in an animal model of anxiety. Psychopharmacology (Berlin). 97:1989;277-279.
9. Cassella J., Davis M. Fear-enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in rats. Psychopharmacology (Berlin). 87:1985;278-282.
10. 3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments Neuropharmacology. 35:1996;63-70.
11. Cole J., Rodgers R. Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze. Pharmacol. Biochem. Behav. 52:1995;473-478.
12. Commissaris R., Ellis D., Hill T., Schefke D., Becker C., Fontana D. Chronic antidepressant and clonidine treatment effects on conflict behavior in the rat. Pharmacol. Biochem. Behav. 37:1990;167-176.
13. Cook L., Davidson A.B. Effects of behaviorally active drugs in a conflict-punishment procedure in rats. Garattini S., Mussini E., Randall L.O. The benzodiazepines. 1973;327-345 Raven Press, New York.
14. Coplan J., Gorman J., Klein D. Serotonin related function in panic-anxiety. A critical overview Neuropharmacology. 6:1992;189-200.
15. Costall B., Jones B., Kelly M., Naylor R., Tomkins D. Exploration of mice in a black and white test box. Validation as a model of anxiety Pharmacol. Biochem. Behav. 32:1989;777-785.
16. 3 antagonists and benzodiazepines. Their comparative behavioural pharmacology:1991;133-157 John Wiley & Sons, Chichester, U.K.:
17. File S. Animal models for predicting clinical efficacy of anxiolytics. Social behavior Neuropsychobiology. 13:1985;55-62.
18. File S., Johnston A. Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat. Neuropsychobiology. 17:1987;187-192.
19. Fontana D., Carbary T., Commissaris R. Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat. Psychopharmacology (Berlin). 98:1989;157-162.
20. Fontana D., Commissaris R. Effects of acute and chronic imipramine administration on conflict behavior in the rat. A potential "animal model" for the study of panic disorder? Psychopharmacology (Berlin). 95:1988;147-150.
21. Gao B., Cutler M. Effects of acute and chronic administration of the antidepressants, imipramine, phenelzine and mianserin, on the social behavior of mice. Neuropharmacology. 33:1994;813-824.
22. Geller J., Seifter J. The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia. 1:1960;482-492.
23. 4 receptors in rats. Naunyn Schmiedebergs Arch. Pharmacol. 356:1997;22-28.
24. Haefely, W.; Pieri, L.; Polc, P.; Schaffner, R.: General pharmacology and neuropharmacology of benzodiazepine derivatives. In: Hoffmeister, F.; Stille, G., eds. Handbook of experimental pharmacology, 55 (Part II). Berlin: Springer Verlag; 1981:13-262.
25. Hamm R., Lyeth B. Nociceptive thresholds following food restriction and return to free-feeding. Physiol. Behav. 33:1984;499-501.
26. Handley S., McBlane J. 5-HT drugs in animal models of anxiety. Psychopharmacology (Berlin). 112:1993;13-20.
27. Hersh E., Kaplan P. Antinociceptive action of tricyclic antidepressant drugs in the rat. Anesth. Prog. 37:1990;186-189.
28. 2C and corticosteroid receptor gene expression in the hippocampus with food restriction and glucocorticoids. J. Neurosci. 17:1997;4056-4065.
29. 2 receptors in rat brain. An autoradiographic study Synapse. 14:1993;324-331.
30. ICD-10.: Classification of mental and behavioral disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
31. 1A receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex. Pharmacol. Biochem. Behav. 54:1996;143-147.
32. Kahn R., McNair D., Lipman R., Covi L., Rickels K., Downing R., Fisher S., Frankenthaler L. Imipramine and chlordiazepoxide in depressive and anxiety disorders. 2. Efficacy in anxious outpatients Arch. Gen. Psychiatry. 43:1986;79-85.
33. Kramer E., Bodnar R. Age-related decrements in morphine analgesia. A parametric analysis Neurobiol. Aging. 7:1986;185-191.
34. Lydiard R., Ballenger J. Antidepressants in panic disorder and agoraphobia. J. Affective Disord. 13:1987;153-168.
35. 3H]noradrenaline in the rat hippocampus. Eur. J. Pharmacol. 271:1994;121-129.
36. 3H]Harmaline as a specific ligand of MAO-A. II. Measurement of the turnover rates of MAO-A during ontogenesis in the rat brain. J. Neurochem. 32:1979;1829-1836.
37. Nutt D., Glue P. Clinical pharmacology of anxiolytics and antidepressants. A psychopharmacological perspective Pharmacol. Ther. 44:1989;309-334.
38. 2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment. J. Pharmacol. Exp. Ther. 246:1988;956-962.
39. Peroutka S., Snyder S. Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science. 210:1980;88-90.
40. 3H]spiroperidol by chronic treatment with the antidepressant amitriptyline. J. Pharmacol. Exp. Ther. 215:1980;582-587.
41. Ramzan I., Wong B., Corcoran G. Pain sensitivity in dietary-induced obese rats. Physiol. Behav. 54:1993;433-435.
42. Rigal F., Eschalier A., Devoize J.L., Pechadre J.C. Activities of five antidepressants in a behavioral pain test in rats. Life Sci. 32:1983;2965-2971.
43. Soubrié P., Martin P., Massol J., Gaudel G. Attenuation of response to antidepressants in animals induced by reduction in food intake. Psychiatry Res. 27:1989;149-159.
44. Spurlock G., Buckland P., O'Donovan M., McGuffin P. Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology. 33:1994;433-440.
45. Stone E.A. Reduction in cortical beta adrenergic receptor density after chronic intermittent food deprivation. Neurosci. Lett. 40:1983;33-37.
46. 2A receptors without affecting benzodiazepine binding sites in rat brain. Cell. Mol. Neurobiol. 15:1995;361-370.
47. Wladystawa D., Adamus A., Melzacka M., Szymura J. The route of administration of imipramine as a factor affecting formation of its metabolite. J. Pharm. Pharmacol. 34:1982;678-680.
48. Zhou D., Huether G., Wiltfang J., Hajak G., Rüther E. Serotonin transporters in the rat frontal cortex. Lack of circadian rhymicity but down-regulation by food restriction J. Neurochem. 67:1996;656-661.